Poster Abstracts
Grand Hall CD (Manchester Grand Hyatt)
The Role of Tuberculin Skin Test As a Guide to Preventive Chemotherapy for Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplantation in a Region with Intermediate Prevalence and Routine BCG Vaccination: A Preliminary Report from Turkey
Sahika Zeynep Aki, MD, Gazi University Faculty of Medicine;
Gulsan Turkoz Sucak, MD, Gazi University Faculty of Medicine;
Ozlem Guzel Tunccan, MD, Gazi University Faculty of Medicine;
Nurdan Kokturk, MD, Gazi University Faculty of Medicine;
Esin Senol, MD, Gazi University Faculty of Medicine
Nasal Endoscopy in the Evaluation of Prolonged Febrile Events in Children Undergoing Hematopoietic STEM CELL Transplantation
Victor Aquino, MD, University of Texas Southwestern Medical Center;
Sharon Holmes, MPH MT(ASCP), Childrens Medical Center Dallas;
Kerrie Olivarez, RN, Childrens Medical Center Dallas;
James DeMasi, RN, CPNP-AC, Children's Medical Center Dallas;
Tiffany Simms-Waldrip, MD, University of Texas Southwestern Medical Center at Dallas;
Andrew Young Koh, MD, University of Texas Southwestern Medical Center;
Jane Siegel, MD, University of Texas Southwestern Medical Center at Dallas
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
William L Marshall, Merck;
Cyrus Badshah, Merck;
Fang Liu, Merck;
Walter Kraft, MD, Thomas Jefferson University Hospital;
Francheska Colon-Gonzalez, Merck;
Arne van Schanke, Quantitative Solutions, B.V.;
Joanna Udo de Haes, PRA Health Sciences;
Bhavna Kantesaria, Merck;
Ellen Hulskotte, Astella Pharma, B.V.;
Carolyn Cho, Merck;
Joan R Butterton, Merck;
Eugene E Marcantonio, Merck
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
Valkal Bhatt, Pharm.D., Memorial Sloan Kettering Cancer Center;
Leyla Shune, MD, Memorial Sloan Kettering Cancer Center;
Emily Lauer, BS, Memorial Sloan Kettering Cancer Center;
Marissa Lubin, BA, Memorial Sloan Kettering Cancer Center;
Sean Devlin, PhD, Memorial Sloan Kettering Cancer Center;
Andromachi Scaradavou, MD, Memorial Sloan Kettering Cancer Center;
Nancy A Kernan, MD, Memorial Sloan Kettering Cancer Center;
Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Rekha Parameswaran, MD, Memorial Sloan Kettering Cancer Center;
Miguel-Angel Perales, MD, Memorial Sloan Kettering Cancer Center;
Doris M. Ponce, MD, Memorial Sloan Kettering Cancer Center;
Gerald A Soff, MD, Memorial Sloan Kettering Cancer Center;
Juliet Barker, MBBS (Hons) FRACP, Memorial Sloan Kettering Cancer Center
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Sharat Chandra, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Kana Mizuno, Cincinnati Children's Hospital Medical Center;
Tsuyoshi Fukuda, PhD, Cincinnati Childen's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center;
Richard Tarin, CCHMC;
Ashley Teusink, PharmD, MBA, BCPS, Cincinnati Children's Hospital Medical Center;
Michelle Spaulding, Cincinnati Children's Hospital Medical Center;
Michael S. Grimley, MD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Michael B Jordan, MD, Cincinnati Children's Hospital Medical Center;
Rebecca A. Marsh, MD, Cincinnati Children's Hospital Medical Center;
Ashish Kumar, MD, PhD, Cincinnati Children's Hospital Medical Center;
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Pooja Khandelwal, MD, Cincinnati Children's Hospital Medical Center;
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Alexander Vinks, PharmD, PhD, FCP, Cincinnati Children's Hospital Medical Center;
Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center
The Incidence and Outcomes of Oral Mucositis Among Allogeneic Stem Cell Transplantation Patients: A Systematic Review and Meta-Analysis
Hafsa Myedah Chaudhry, Mayo Medical School;
Alison J Bruce, M.B., Ch.B, Mayo Clinic;
Robert Wolf, PharmD, Mayo Clinic;
Mark R. Litzow, MD, Mayo Clinic Rochester;
William Hogan, MBBCh, Mayo Clinic;
Dennis A. Gastineau, MD, Mayo Clinic;
Mrinal Patnaik, MBBS, Mayo Clinic;
Larry Prokop, MSL, Mayo Clinic;
Shahrukh Hashmi, MD, MPH, Mayo Clinic Rochester
Bacteremia during Neutropenic Episodes in Children Underwent Hematopoietic Stem Cell Transplantation Receiving Ciprofloxacin and Penicillin Prophylaxis
Worawut Choeyprasert, Chiang Mai University Hospital;
Samart Pakakasama, MD, Faculty of Medicine Ramathibodi hospital, Mahidol University;
Suradej Hongeng, MD, Faculty of Medicine Ramathibodi hospital, Mahidol University;
Usanarat Anurathapan, MD, Faculty of Medicine Ramathibodi hospital, Mahidol University
Incidence and Outcome of Rhinovirus in Children Undergoing Hematopoietic Stem Cell Transplantation
James DeMasi, RN, CPNP-AC, Children's Medical Center Dallas;
Victor Aquino, MD, University of Texas Southwestern Medical Center;
Tiffany Simms-Waldrip, MD, University of Texas Southwestern Medical Center at Dallas;
Andrew Young Koh, MD, University of Texas Southwestern Medical Center;
Sharon Holmes, MPH MT(ASCP), Childrens Medical Center Dallas
Evaluating Neutropenia Recovery in Patients Receiving Filgrastim on Day +5 Versus Day +10 Post Autologous Hematopoietic Stem Cell Transplant
Lisa Marie DiGrazia, PharmD, BCPS, BCOP, Rush University Medical Center;
Laura Geswein, PharmD, BCPS, Rush University Medical Center;
Marissa Janusek, PharmD, University of Illinois at Chicago;
Kathryn Schultz, PharmD, BCPS, BCOP, Rush University Medical Center;
Christopher W. Crank, PharmD, BCPS, MS, AQ-ID, Rush-Copley Medical Center;
Henry C Fung, MD, Rush University Medical Center
A Multi-Institutional Retrospective Study Suggests That Optimal Enteral Nutrition (EN) Influences Outcomes after Hematopoietic Stem Cell Transplantation in Children and Adults
Jackie Dioguardi, MSHS, PA-C, Children's National Medical Center;
Elyse Bryson, PA-C, Children's Healthcare of Atlanta;
Sameeya Ahmed-Winston, MSN, CPNP, Children's National Medical Center;
Gretchen Vaughn, MSN, CNP, All Children's Hospital;
Susan Slater, FNP, Oregon Health & Science University;
Jessica Driscoll, MSN, ANP-BC, Massachusetts General Hospital;
Evelio Perez-Albuerne, MD, PhD, Children's National Medical Center;
Kirsten M. Williams, MD, CNMC/National Cancer Institute, NIH
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Ossama Maher, MD, University of Texas MD Anderson Cancer Center;
Jorge Galvez Silva, MD, University of Texas MD Anderson Cancer Center;
Chloe Tillman, MSN, RN, CPN, University of Texas MD Anderson Cancer Center;
Demetrios Petropoulos, MD, University of Texas MD Anderson Cancer Center;
Laurence J.N. Cooper, MD, PhD, University of Texas MD Anderson Cancer Center;
Dean Lee, MD, PhD, University of Texas MD Anderson Cancer Center;
Laura L Worth, MD, PhD, University of Texas MD Anderson Cancer Center;
Richard E. Champlin, MD, The University of Texas MD Anderson Cancer Center;
Nidale Tarek, MD, University of Texas MD Anderson Cancer Center;
Priti Tewari, MD, University of Texas MD Anderson Cancer Center
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Manish Sharma, MD, Thomas Jefferson University;
Mahasweta Gooptu, MD, Thomas Jefferson University Hospital;
Thomas Klumpp, MD, Thomas Jefferson University Hospital;
Neeraj Saini, MD, Thomas Jefferson University;
Ashok Mandala, MD, Thomas Jefferson University;
Sherilyn Tuazon, MD, Thomas Jefferson University;
Srikanth Nagalla, MD, Thomas Jefferson University;
John Wagner, MD, Thomas Jefferson University;
Margaret Kasner, MD, Thomas Jefferson University;
Onder Alpdogan, MD, Thomas Jefferson University;
Ubaldo Martinez, MD, Kimmel Cancer Center, Thomas Jefferson University;
Dolores Grosso, DNP, Thomas Jefferson University;
Joanne Filicko, MD, Thomas Jefferson University Hospital;
Barbara Pro, MD, Thomas Jefferson University;
Matthew Carabasi, MD, Thomas Jefferson University;
Neal Flomenberg, MD, Thomas Jefferson University;
Mark Weiss, MD, Thomas Jefferson University
Combination Antifungal Therapy Experience at an Academic Health System
David R Ha, PharmD, UC San Diego Healthsystem;
Nina Haste, PharmD, PhD, UC San Diego Healthsystem;
Charles James, PharmD, UC San Diego Healthsystem;
Katherine Medley, PharmD, UC San Diego Healthsystem;
Randy Taplitz, MD, University of California, San Diego
Posaconazole DR Tablet Serum Concentrations in the Bone Marrow Transplant Population: Association with Prevention or Treatment of Invasive Fungal Infections
Nina Haste, PharmD, PhD, UC San Diego Healthsystem;
David R Ha, PharmD, UC San Diego Healthsystem;
Katherine Medley, PharmD, UC San Diego Healthsystem;
Charles James, PharmD, UC San Diego Healthsystem;
Randy Taplitz, MD, University of California, San Diego
A Study of Dietary Intake and the Relationship to Neutrophil Engraftment Among Outpatient Hematopoietic Stem Cell Transplant Patients with Multiple Myeloma
Joy R Heimgartner, MS, RD, CSO, LD, Mayo Clinic;
Shahrukh Hashmi, MD, MPH, Mayo Clinic Rochester;
Francis Buadi, MD, Mayo Clinic;
Joan Vruwink, RD, LD, Mayo Clinic;
William Hogan, MBBCh, Mayo Clinic
Predictors and Outcomes of Intensive Care Utilization in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant at Mayo Clinic, Florida
Demetria Ileana Jacks, MD, Mayo Clinic;
Erin Mobley, MPH, Mayo Clinic;
Colleen Thomas, MS, Mayo Clinic;
Laura Finn, MD, Mayo Clinic;
James Foran, MD, Mayo Clinic;
Vivek Roy, M.D., Mayo Clinic
Implementation of Chemotherapy Order and Administration Checklists Ensures Adherence to National Chemotherapy Guidelines
Mary Krivoy, RN, BSN, OCN, Texas Transplant Institute;
Carole Elledge, RN, MSN, AOCN, Methodist Hospital;
Cheryl Downey, RN, Methodist Healthcare
Rates of Infection and Pathogen Detection for Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Lauren E. Lee, MD, Capt, USAF, MC, San Antonio Military Medical Center;
Alice E. Barsoumian, MD, Maj, USAF, MC, San Antonio Military Medical Center;
Alexander W. Brown, MD, MAJ, USA, MC, San Antonio Military Medical Center;
Michael A. Wiggins, MD, LTC, USA, MC, San Antonio Military Medical Center;
John S. Renshaw, MD, Lt Col, USAF, MC, San Antonio Military Medical Center;
Michael B. Osswald, MD, Ret Col, USAF, MC, San Antonio Military Medical Center;
Clinton K. Murray, MD, COL USA, MC, San Antonio Military Medical Center
Safety and Feasibility of Administering Lactobacillus Plantarum to Children Undergoing Myeloablative Hematopoietic Cell Transplantation (HCT)
Michael L. Nieder, MD, H. Lee Moffitt Cancer Center and Research Institute;
Elena J Ladas, PhD, RD, Columbia University;
Monica Bhatia, MD, Columbia University;
Michael Gates, RN, CCRP, All Children's Hospital Johns Hopkins Medicine;
Frances Hamblin, RN, BSN, CPHON, CCRP, All Children's Hospital Johns Hopkins Medicine;
Aleksandra Petrovic, MD, All Children's Hospital Johns Hopkins Medicine;
Lu Chen, PhD, Children's Oncology Group Statistical Data Center and University of Southern California;
Eric Sandler, MD, Nemours Children's Clinic;
David Berman, DO, All Children's Hospital Johns Hopkins Medicine
Clostridium Difficile Infection in Patients Undergoing Hematopoietic Cell Transplantation. Results from the Transplantation Group at the Catholic University Hospital in Santiago, Chile
Javier Pilcante, MD, Pontifical Catholic University;
Patricio Rojas, MD, Pontifical Catholic University;
Daniel Ernst, MD, Pontifical Catholic University;
Mauricio Sarmiento, MD, Pontifical Catholic University;
Mauricio Ocqueteau, MD, Pontifical Catholic University;
Pablo Bertin, MD, Pontifical Catholic University;
Maria Jose Garcia, MD, Pontifical Catholic University;
Maria Alejandra Rodriguez, MD, Pontifical Catholic University;
Veronica Jara, RN, Pontifical Catholic University;
Pablo A Ramirez, MD, Pontifical Catholic University
Nutritional Assessment As Predictor of Complications Post Hematopoietic Cell Transplantation
Marcela Espinoza, MD, Pontifical Catholic University;
Roberto Olmos, MD, Pontifical Catholic University;
Javiera Perelli, MD, Pontifical Catholic University;
Jessica Liberona, RD, Pontifical Catholic University;
Veronica Jara, RN, Pontifical Catholic University;
Julieta Klaassen, MD, Pontifical Catholic University;
Pablo A Ramirez, MD, Pontifical Catholic University
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Jeffrey Schriber, MD, Cancer Transplant Institute;
Andrew Szetela, PharmD, BCOP, Cancer Transplant Institute;
Aleksandra Schriber, Knox College;
Eileen Simpson, BS, MT, Cancer Transplant Institute;
Donald Israel, BSc, Cancer Transplant Institute;
Gail Sulski, MS, FNP, Cancer Transplant Institute;
Nicole Thurman, MS, FNP, Cancer Transplant Institute;
Rochelle Chiffelle, DNP, Cancer Transplant Institute;
Kate Steenstra, MS, FNP, Cancer Transplant Institute;
Denise Gibson, RN, MSN, Cancer Transplant Institute;
Selma Kendrick, RN MS, Cancer Transplant Institute;
Jonathan Abbas, M.D., Cancer Transplant Institute;
Adrienne Briggs, MD, Cancer Transplant Institute
A Quality Improvement Project to Decrease Clostridium Difficile Associated Infection in a Bone Marrow Transplant Unit: A Multidisciplinary Approach
Juan J Toro, MD, MSCI, South Texas Veterans Health Care System;
Jose A Cadena, MD, South Texas Veterans Health Care System;
Sarah Meinzen, BSN, RN, South Texas Veterans Health Care System;
Sandra Shaw, BSN, RN, South Texas Veterans Health Care System;
Megan McKee, Pharm D, South Texas Veterans Health Care System;
Bonita Neumon, PA, South Texas Veterans Health Care System;
Francisca Gushiken, MD, South Texas Veterans Health Care System;
David J Haile, MD, South Texas Veterans Health Care System;
Cesar O. Freytes, MD, South Texas Veterans Health Care System
Tbo or Not Tbo-That Is the Question!
Steven Trifilio, BSPharm, Northwestern Memorial Hospital;
Zheng Zhou, University of Massachusetts;
Jessica l Fong, Northwestern Memorial Hospital;
John P Galvin, MD, Northwestern University Feinberg School of Medicine;
Joanne Monreal, Northwestern Memorial Hospital;
Rafi Farhan, Northwestern Memorial Hospital;
Marcelo Villa, BS MT(ASCP), Northwestern Memorial Hospital;
Jayesh Mehta, MD, Northwestern University Feinberg School of Medicine
Related Donor Screening: An Increasingly Complex Process
Tara Wolff, NP, Memorial Sloan Kettering Cancer Center;
Molly Maloy, MS, Memorial Sloan Kettering Cancer Center;
Shannon Andersen, MSN, FNP-BC, OCN, Memorial Sloan Kettering Cancer Center;
Abigail Cohen, NP, Memorial Sloan Kettering Cancer Center;
Shani Irby, NP, Memorial Sloan Kettering Cancer Center;
Nicole J. LeStrange, NP, Memorial Sloan Kettering Cancer Center;
Megan Scott, NP, Memorial Sloan Kettering Cancer Center;
Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Ann A. Jakubowski, PhD, MD, Memorial Sloan Kettering Cancer Center
Recurrent Late Cytomegalovirus Disease after Hematopoietic Cell Transplantation (HCT): Incidence, Clinical Manifestations, Risk Factors and Outcome
Sezen Özkök, MD, Fred Hutchinson Cancer Research Center;
Hu Xie, MS, Fred Hutchinson Cancer Research Center;
Zach Stednick, MPH, Fred Hutchinson Cancer Research Center;
Sachiko Seo, MD, PhD, Fred Hutchinson Cancer Research Center;
Michael J. Boeckh, MD, Fred Hutchinson Cancer Research Center;
Margaret L. Green, MD, MPH, Fred Hutchinson Cancer Research Center
![[Visit Client Website]](images/banner.gif)